KR101176380B1 - 모낭충 감염증 치료를 위한 조성물 및 방법 - Google Patents

모낭충 감염증 치료를 위한 조성물 및 방법 Download PDF

Info

Publication number
KR101176380B1
KR101176380B1 KR1020107005936A KR20107005936A KR101176380B1 KR 101176380 B1 KR101176380 B1 KR 101176380B1 KR 1020107005936 A KR1020107005936 A KR 1020107005936A KR 20107005936 A KR20107005936 A KR 20107005936A KR 101176380 B1 KR101176380 B1 KR 101176380B1
Authority
KR
South Korea
Prior art keywords
delete delete
tea tree
demodex
tree oil
ointment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020107005936A
Other languages
English (en)
Korean (ko)
Other versions
KR20100052541A (ko
Inventor
가오 잉-잉
쉐퍼 씨 지 쳉
Original Assignee
티슈테크, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 티슈테크, 인코포레이티드 filed Critical 티슈테크, 인코포레이티드
Publication of KR20100052541A publication Critical patent/KR20100052541A/ko
Application granted granted Critical
Publication of KR101176380B1 publication Critical patent/KR101176380B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020107005936A 2007-08-29 2008-08-28 모낭충 감염증 치료를 위한 조성물 및 방법 Expired - Fee Related KR101176380B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/846,961 US8128968B2 (en) 2007-08-29 2007-08-29 Compositions and methods for treating Demodex infestations
US11/846,961 2007-08-29
PCT/US2008/074674 WO2009032773A2 (en) 2007-08-29 2008-08-28 Compositions and methods for treating demodex infestations

Publications (2)

Publication Number Publication Date
KR20100052541A KR20100052541A (ko) 2010-05-19
KR101176380B1 true KR101176380B1 (ko) 2012-08-24

Family

ID=40407911

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107005936A Expired - Fee Related KR101176380B1 (ko) 2007-08-29 2008-08-28 모낭충 감염증 치료를 위한 조성물 및 방법

Country Status (8)

Country Link
US (3) US8128968B2 (https=)
EP (1) EP2192913A4 (https=)
JP (1) JP2010538011A (https=)
KR (1) KR101176380B1 (https=)
CN (2) CN104189091A (https=)
CA (1) CA2694767C (https=)
HK (1) HK1204277A1 (https=)
WO (1) WO2009032773A2 (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006119174A1 (en) 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
US20090317503A1 (en) * 2008-06-20 2009-12-24 Ocusoft, Inc. Eyelid Preparation and Method of Use
US8895080B2 (en) 2008-06-20 2014-11-25 Ocusoft, Inc. Compositions and kits for ocular treatment
KR101022550B1 (ko) 2009-06-02 2011-03-16 고인순 모낭충 제거 효과를 갖는 크렌징 조성물
KR101792778B1 (ko) 2010-10-26 2017-11-01 삼성전자주식회사 비휘발성 메모리 장치 및 그 형성 방법
US20130331768A1 (en) * 2010-12-29 2013-12-12 Louis D. Nichamin Eye treatment
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
IL217807A (en) 2012-01-29 2017-01-31 Tel-Ari Ruben Local medical preparations based on tto
CN103055158A (zh) * 2012-12-27 2013-04-24 王荣华 一种治疗鳞屑性睑缘炎的中药组合物
WO2019126541A1 (en) * 2017-12-20 2019-06-27 Attillaps Holdings Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
US11446241B2 (en) * 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
DE102013223789A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223795A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223793A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223792A1 (de) 2013-11-21 2015-05-21 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223790A1 (de) 2013-11-21 2015-05-21 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
WO2015183799A1 (en) 2014-05-28 2015-12-03 Macular Health, Llc Ocular eyelid scrub composition for the treatment of demodex blepharitis
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
LT3157534T (lt) * 2014-06-19 2022-09-12 Attillaps Holdings Acetilcholinesterazės inhibitoriai, skirti dermatologinių būklių gydymui
RU2558074C1 (ru) * 2014-07-08 2015-07-27 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт ветеринарной энтомологии и арахнологии" (ФГБНУ ВНИИВЭА) Способ лечения демодекоза крупного рогатого скота
WO2016010984A2 (en) * 2014-07-14 2016-01-21 Tissue Tech, Inc. Compositions and methods for treating rosacea
US20170232024A1 (en) 2014-08-04 2017-08-17 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
ES3007759T3 (en) 2015-09-28 2025-03-20 Azura Ophthalmics Ltd Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
CN114469991A (zh) 2016-04-14 2022-05-13 阿祖拉眼科有限公司 用于治疗睑板腺功能障碍的二硫化硒组合物
IT201600096125A1 (it) 2016-09-26 2018-03-26 Ntc Srl Complesso e composizioni per il trattamento di affezioni oculari e cutanee
RU2652073C1 (ru) * 2017-04-28 2018-04-24 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский государственный университет" (ТГУ, НИ ТГУ) Способ лечения блефарита
EP3415142B1 (en) 2017-06-12 2020-12-09 Novax Pharma S.A.M. Composition for the treatment of blepharitis containing terpinen-4-ol
WO2019057899A1 (en) 2017-09-22 2019-03-28 Lipid Systems Sp. Z.O.O. AQUEOUS COMPOSITION COMPRISING AT LEAST ONE PHOSHOLIPID AND AT LEAST ONE TERPENE WITH ACIDICITY ACTIVITY AGAINST DEMODEX
WO2019118928A1 (en) 2017-12-15 2019-06-20 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
AU2019309520B2 (en) 2018-07-27 2025-04-03 Aperta Biosciences, Llc Spinosyn formulations for treatment of demodex-induced ocular and facial conditions
CN109077947A (zh) * 2018-08-30 2018-12-25 湖北舒邦药业有限公司 一种医用眼科冷敷敷料及其制备方法
BR112021006821A2 (pt) * 2018-10-12 2021-07-13 Hovione Scientia Limited método de tratamento de inflamação e patologias oftálmicas, dispersão sólida, formulação farmacêutica, método de matar ácaros e kit
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
US12161752B2 (en) * 2019-08-20 2024-12-10 Vishwanath Padmanabhan Compositions and methods for the treatment of anterior blepharitis and posterior blepharitis
CN114980895A (zh) * 2019-11-04 2022-08-30 阿祖拉眼科有限公司 针对蠕形螨及其相关病症的计量剂量
CA3166357A1 (en) 2020-01-10 2021-07-15 Azura Ophthalmics Ltd. Instructions for composition and sensitivity
CN111297948B (zh) * 2020-02-13 2021-12-14 周立光 一种治疗蠕形螨睑缘炎的眼贴和制备方法
CN111265666A (zh) * 2020-03-20 2020-06-12 山东省眼科医院 一种治疗螨虫性睑缘炎的茶树油制剂及其制备方法
WO2022212399A1 (en) * 2021-03-30 2022-10-06 Spallitta Frank Anthony Anti-parasitic compounds for the treatment and prevention of viral diseases
WO2023211823A1 (en) 2022-04-25 2023-11-02 Biotissue Holdings Inc. Compositions and methods relating to pooled fetal support tissue
CN116602879B (zh) * 2023-04-25 2026-02-10 马应龙大健康有限公司 一种除螨组合物、含有该组合物的除螨添加剂及其制备方法及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006119174A1 (en) * 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
AU559001B2 (en) * 1980-09-05 1987-02-19 Sedgewick, S.E. Skin cream containing tea tree oil
US4745100A (en) * 1985-05-14 1988-05-17 Eye Research Institute Of Retina Foundation Stimulation of tear secretion
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
CA1296329C (en) * 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
JPH04198131A (ja) * 1990-11-28 1992-07-17 Takeda Chem Ind Ltd 創傷治癒促進剤およびそれを含有する外用組成物
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
DE19511429A1 (de) * 1995-03-29 1996-10-02 Gerhard Linnhoff Pflegemittel für Haustiere und seine Anwendungen
US6022529A (en) * 1997-08-06 2000-02-08 California Institute Of Technology Photoresponsive sunscreen compositions
US6197305B1 (en) * 1998-01-05 2001-03-06 Farmo-Nat Ltd. Anti-fungal compositions with prolonged activity
DE19824681A1 (de) 1998-06-03 1999-12-09 Grewe Helmut F Milben tötendes Reinigungsmittel für Körper und Haare
GB2370989A (en) * 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
US20010051184A1 (en) * 1999-05-20 2001-12-13 Madalene C.Y. Heng Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
WO2001012225A1 (en) 1999-08-10 2001-02-22 Santen Pharmaceutical Co., Ltd. Water channel opener compositions and medicinal compositions for ophthalmic use
US20040235742A1 (en) 1999-08-10 2004-11-25 Santen Pharmaceutical Co., Ltd. Water channel opener compositions and medicinal compositions for ophthalmic use
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6541042B1 (en) * 1999-10-27 2003-04-01 Bogar Ag Therapeutically effective combination
GB2362574B (en) * 2001-01-12 2002-04-24 Angus Erskine Stuart A formulation for the destruction of the eggs of chicken mites (Dermanyssus Gallinae)
US7121666B2 (en) 2001-04-25 2006-10-17 Tseng Scheffer C G Apparatus and method for the kinetic analysis of tear stability
EP1389911A1 (en) * 2001-05-09 2004-02-25 Medicis Pharmaceutical Corporation Ectoparasiticidal compositions and methods of their use
IL158509A (en) * 2003-10-20 2010-11-30 Biomor Israel Ltd Non-phytotoxic biocide composition containing tea tree oil and method for production thereof
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20040197364A1 (en) * 2003-01-24 2004-10-07 Brown Paul R. Topical insect repellent
RU2388225C2 (ru) 2003-04-24 2010-05-10 "ТАЙРАТЕК, ЛЛСи" Композиции и способы борьбы с насекомыми
US20050220742A1 (en) * 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US20060068044A1 (en) * 2004-09-30 2006-03-30 Max Reynolds Antimicrobial compositions and applications therefore
US20060147408A1 (en) * 2005-01-06 2006-07-06 Vision Endurance Resource, Inc. Skin cleansing and sloughing solution
US20060188492A1 (en) 2005-01-13 2006-08-24 Chronorx Llc, An Alaska Limited Liability Company Topical management of ocular and periocular conditions
US9078845B2 (en) * 2005-01-20 2015-07-14 Kayban Pty Ltd Anti-microbial agent
US7875620B2 (en) * 2005-06-30 2011-01-25 Piper Medical, Inc. Methods of treating microbial infections
JPWO2007145344A1 (ja) 2006-06-16 2009-11-12 ロート製薬株式会社 テルペノイドを含有するソフトコンタクトレンズ用眼科組成物
US8202853B2 (en) * 2006-11-03 2012-06-19 Ocusoft, Inc. Convenience kit for eyelid treatment
US8128968B2 (en) 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006119174A1 (en) * 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex

Also Published As

Publication number Publication date
US20090061025A1 (en) 2009-03-05
CN101795700A (zh) 2010-08-04
US20130224272A1 (en) 2013-08-29
US20100273870A1 (en) 2010-10-28
US8128968B2 (en) 2012-03-06
EP2192913A2 (en) 2010-06-09
WO2009032773A3 (en) 2009-04-30
US8455015B2 (en) 2013-06-04
EP2192913A4 (en) 2011-03-02
JP2010538011A (ja) 2010-12-09
CN104189091A (zh) 2014-12-10
HK1204277A1 (en) 2015-11-13
CA2694767A1 (en) 2009-03-12
KR20100052541A (ko) 2010-05-19
US8865233B2 (en) 2014-10-21
CA2694767C (en) 2017-11-07
WO2009032773A2 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
KR101176380B1 (ko) 모낭충 감염증 치료를 위한 조성물 및 방법
US8440240B2 (en) Method for treating ocular demodex
Tighe et al. Terpinen-4-ol is the most active ingredient of tea tree oil to kill Demodex mites
Kheirkhah et al. Corneal manifestations of ocular demodex infestation
Gao et al. Treatment of ocular itching associated with ocular demodicosis by 5% tea tree oil ointment
AU2024204272A1 (en) Compositions and Methods of Use
KR20190057324A (ko) 안검염 치료에 사용되는 약제학적 조성물
JP6448545B2 (ja) 眼科用又は耳鼻科用水性組成物
CN101478881A (zh) 治疗眼睑、眼表面、皮肤或耳感染或感染性定植的方法及组合物
WO2016022066A1 (en) Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
US20160287566A1 (en) Anti-demodectic active agents and topical compositions for the treatment of demodicosis in humans and animals
JP2023522772A (ja) ホコウエイ及びそのモノマー化合物のダニ殺滅への使用
Hakim et al. Medical management of blepharitis
US20150118333A1 (en) Novel compositions and uses thereof
O’Haver et al. Dermatological Problems
de Groot An overview of Demodex Folliculorum
HK1220913B (zh) 眼科用或耳鼻科用水性组合物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20150805

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20160805

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20170818

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20170818

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301